Open Access
ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria
Milica Milivojevic
1
,
Anne Sophie Dangeard
1
,
Christoph Alexander Kasper
2
,
Therese Tschon
2
,
Mario Emmenlauer
2
,
Claudine Pique
1
,
Pamela Schnupf
3
,
Julie Guignot
1
,
Cécile Arrieumerlou
1
1
3
Institut Imagine, UMR_S1163, Paris, France
|
Publication type: Journal Article
Publication date: 2017-02-21
scimago Q1
wos Q1
SJR: 1.987
CiteScore: 10.2
Impact factor: 4.9
ISSN: 15537366, 15537374
PubMed ID:
28222186
Molecular Biology
Genetics
Microbiology
Immunology
Parasitology
Virology
Abstract
During infection by invasive bacteria, epithelial cells contribute to innate immunity via the local secretion of inflammatory cytokines. These are directly produced by infected cells or by uninfected bystanders via connexin-dependent cell-cell communication. However, the cellular pathways underlying this process remain largely unknown. Here we perform a genome-wide RNA interference screen and identify TIFA and TRAF6 as central players of Shigella flexneri and Salmonella typhimurium-induced interleukin-8 expression. We show that threonine 9 and the forkhead-associated domain of TIFA are necessary for the oligomerization of TIFA in both infected and bystander cells. Subsequently, this process triggers TRAF6 oligomerization and NF-κB activation. We demonstrate that TIFA/TRAF6-dependent cytokine expression is induced by the bacterial metabolite heptose-1,7-bisphosphate (HBP). In addition, we identify alpha-kinase 1 (ALPK1) as the critical kinase responsible for TIFA oligomerization and IL-8 expression in response to infection with S. flexneri and S. typhimurium but also to Neisseria meningitidis. Altogether, these results clearly show that ALPK1 is a master regulator of innate immunity against both invasive and extracellular gram-negative bacteria.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Gut Microbes
6 publications, 5.26%
|
|
|
Nature Communications
4 publications, 3.51%
|
|
|
Nature
4 publications, 3.51%
|
|
|
Frontiers in Cellular and Infection Microbiology
3 publications, 2.63%
|
|
|
EMBO Reports
3 publications, 2.63%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.75%
|
|
|
Frontiers in Microbiology
2 publications, 1.75%
|
|
|
Frontiers in Immunology
2 publications, 1.75%
|
|
|
Genetics Selection Evolution
2 publications, 1.75%
|
|
|
Cellular and Molecular Life Sciences
2 publications, 1.75%
|
|
|
Current Opinion in Immunology
2 publications, 1.75%
|
|
|
Scientific Reports
2 publications, 1.75%
|
|
|
PLoS Pathogens
2 publications, 1.75%
|
|
|
Carbohydrate Research
2 publications, 1.75%
|
|
|
Current Opinion in Microbiology
2 publications, 1.75%
|
|
|
Cell Reports
2 publications, 1.75%
|
|
|
Journal of Cellular and Molecular Medicine
2 publications, 1.75%
|
|
|
FEBS Letters
2 publications, 1.75%
|
|
|
Current Topics in Microbiology and Immunology
2 publications, 1.75%
|
|
|
Virulence
2 publications, 1.75%
|
|
|
mBio
2 publications, 1.75%
|
|
|
International Journal of Medical Microbiology
2 publications, 1.75%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 1.75%
|
|
|
Journal of Immunology
1 publication, 0.88%
|
|
|
Biochemical Journal
1 publication, 0.88%
|
|
|
Science China Life Sciences
1 publication, 0.88%
|
|
|
Journal of Molecular Medicine
1 publication, 0.88%
|
|
|
Tropical Animal Health and Production
1 publication, 0.88%
|
|
|
Journal of Human Genetics
1 publication, 0.88%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
|
|
|
Springer Nature
26 publications, 22.81%
|
|
|
Elsevier
26 publications, 22.81%
|
|
|
Cold Spring Harbor Laboratory
10 publications, 8.77%
|
|
|
Frontiers Media S.A.
8 publications, 7.02%
|
|
|
Taylor & Francis
8 publications, 7.02%
|
|
|
Wiley
7 publications, 6.14%
|
|
|
American Society for Microbiology
4 publications, 3.51%
|
|
|
MDPI
3 publications, 2.63%
|
|
|
Oxford University Press
3 publications, 2.63%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.75%
|
|
|
American Chemical Society (ACS)
2 publications, 1.75%
|
|
|
European Molecular Biology Organization
2 publications, 1.75%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 1.75%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 1.75%
|
|
|
The American Association of Immunologists
1 publication, 0.88%
|
|
|
Portland Press
1 publication, 0.88%
|
|
|
Social Science Electronic Publishing
1 publication, 0.88%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.88%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.88%
|
|
|
Hindawi Limited
1 publication, 0.88%
|
|
|
Annual Reviews
1 publication, 0.88%
|
|
|
Spandidos Publications
1 publication, 0.88%
|
|
|
5
10
15
20
25
30
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
114
Total citations:
114
Citations from 2024:
26
(22.8%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Milivojevic M. et al. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria // PLoS Pathogens. 2017. Vol. 13. No. 2. p. e1006224.
GOST all authors (up to 50)
Copy
Milivojevic M., Dangeard A. S., Kasper C. A., Tschon T., Emmenlauer M., Pique C., Schnupf P., Guignot J., Arrieumerlou C. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria // PLoS Pathogens. 2017. Vol. 13. No. 2. p. e1006224.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1371/journal.ppat.1006224
UR - https://doi.org/10.1371/journal.ppat.1006224
TI - ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria
T2 - PLoS Pathogens
AU - Milivojevic, Milica
AU - Dangeard, Anne Sophie
AU - Kasper, Christoph Alexander
AU - Tschon, Therese
AU - Emmenlauer, Mario
AU - Pique, Claudine
AU - Schnupf, Pamela
AU - Guignot, Julie
AU - Arrieumerlou, Cécile
PY - 2017
DA - 2017/02/21
PB - Public Library of Science (PLoS)
SP - e1006224
IS - 2
VL - 13
PMID - 28222186
SN - 1553-7366
SN - 1553-7374
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Milivojevic,
author = {Milica Milivojevic and Anne Sophie Dangeard and Christoph Alexander Kasper and Therese Tschon and Mario Emmenlauer and Claudine Pique and Pamela Schnupf and Julie Guignot and Cécile Arrieumerlou},
title = {ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria},
journal = {PLoS Pathogens},
year = {2017},
volume = {13},
publisher = {Public Library of Science (PLoS)},
month = {feb},
url = {https://doi.org/10.1371/journal.ppat.1006224},
number = {2},
pages = {e1006224},
doi = {10.1371/journal.ppat.1006224}
}
Cite this
MLA
Copy
Milivojevic, Milica, et al. “ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria.” PLoS Pathogens, vol. 13, no. 2, Feb. 2017, p. e1006224. https://doi.org/10.1371/journal.ppat.1006224.